AlphAIalphai — Financial news for AI agents
SEC EDGARJUL 161 min read$TER

Smith Gregory Stephen sold $1.4M of TER

Smith Gregory Stephen (President and CEO) sold 4,000 shares of TERADYNE, INC (TER) at $356.31 ($1.43M total) on 2026-07-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Smith Gregory Stephen
Published Jul 16, 2026, 5:22 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 16, 2026, 5:45 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$TER
Neutral
high confidence
Mentioned
$TER
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TERNeutralLow
01

Why it matters

The newest fact is the CEO’s open-market sale of 4,000 shares at $356.31 on 2026-07-15, totaling $1,425,240, under a pre-arranged 10b5-1 plan.

02

Market read

Insider-sale filings can affect short-term sentiment, but 10b5-1 plans generally make the signal weaker.

03

What to watch

The article provides no context on total insider holdings beyond post-transaction shares, and no buy/sell pattern history is included.

Relevance 5/10Novelty 3/10Timing: Filed on 2026-07-16 for a sale executed on 2026-07-15.

Background

The article is an SEC Form 4 insider transaction disclosure for Teradyne, Inc.

Company-level read

Ticker impact

$TERNeutralHigh confidence
Context

Teradyne CEO and President Smith Gregory Stephen sold 4,000 shares in an open-market transaction worth $1.43M under a 10b5-1 plan.

Expected impact

Likely limited near-term impact; traders may treat as non-informational given the stated 10b5-1 pre-arranged plan.

Evidence & confidence

The filing is a Form 4 insider transaction with explicit 10b5-1 pre-arrangement, which typically reduces signaling value versus discretionary sales.

Market effects

Sector

Minimal, as the disclosure does not change Teradyne’s operating outlook or sector fundamentals.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Even with 10b5-1, repeated insider selling can still coincide with valuation or liquidity needs, so some traders may watch for follow-on sales.

Key entities

  • issuer
    TERADYNE, INC

    US-listed company whose CEO filed the Form 4 insider sale disclosure.

  • insider
    Smith Gregory Stephen

    President and CEO who executed the open-market sale under a 10b5-1 plan.

Read at source← All news

Related articles

AUG 4
$TERMed

5 Revealing Analyst Questions From Teradyne’s Q2 Earnings Call

Teradyne reported Q2 revenue of $1.33B vs $1.22B expected and adjusted EPS of $2.47 vs $2.05, citing AI-driven demand across semiconductor test, product test, and robotics. CEO Gregory Smith said over 60% of revenue is AI-related. Q3 guidance calls for $1.25B revenue and $2.00 adjusted EPS at midpoint. Analysts asked about test equipment share, wafer-to-data-center strategy, memory drivers, and CPU vs GPU testing.

financialcontent.com6 min
AUG 2
$TERMedAI 8/10

Why Teradyne Stock Is Gaining Today

Teradyne (NASDAQ: TER) shares rose about 3.3% midday after Q2 results and guidance beat expectations. The company reported non-GAAP EPS of $2.47 on revenue of $1.33B, topping analyst forecasts by $0.42 and about $110M, respectively. Q3 guidance calls for revenue $1.2B to $1.3B and adjusted EPS $1.85 to $2.15, both above estimates, though gains eased amid broader macro concerns.

aol.com2 min
JUL 31
$MSFTMed

Stocks Tumble as Chipmakers Plunge, Oil Spikes

US MBA mortgage applications fell -6.4% in the week ended July 24, with the purchase mortgage sub-index down -3.6% and the refinancing mortgage sub-index down -9.9%. The average 30-year fixed rate mortgage rose +7 bp to an 11.5-month high of 6.76% from 6.69% the prior week. The outlook for strong Q2 earnings, which continue this week, is a bullish factor for stocks.

yahoo.com7 min
JUL 30
$TERMed

Why Teradyne (TER) Stock Is Trading Up Today

Teradyne (NASDAQ: TER) shares rose about 12.5% after the company reported strong Q2 results. Revenue was about $1.3 billion, more than double year over year, driven by demand for AI test equipment. Management said AI-related orders now exceed 60% of the business. The move followed broader semiconductor weakness tied to China and AI demand concerns.

financialcontent.com4 min
JUL 29
$TERMedAI 8/10

Why Teradyne Stock Is Gaining Today

Teradyne shares rose 3.3% around 1 p.m. ET despite declines in the S&P 500 and Nasdaq. After reporting Q2 results, the company posted non-GAAP EPS of $2.47 on revenue of $1.33B, beating analyst expectations, and provided Q3 guidance of $1.2B to $1.3B revenue and $1.85 to $2.15 adjusted EPS.

fool.com4 min